These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23419227)

  • 21. Clinical predictors of acute response with quetiapine in psychotic mood disorders.
    Zarate CA; Rothschild A; Fletcher KE; Madrid A; Zapatel J
    J Clin Psychiatry; 2000 Mar; 61(3):185-9. PubMed ID: 10817103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quetiapine fumarate for schizophrenia and bipolar disorder in young patients.
    Ribolsi M; Magni V; Rubino IA
    Drugs Today (Barc); 2010 Aug; 46(8):581-7. PubMed ID: 20830318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of quetiapine during pregnancy.
    Taylor TM; O'Toole MS; Ohlsen RI; Walters J; Pilowsky LS
    Am J Psychiatry; 2003 Mar; 160(3):588-9. PubMed ID: 12611848
    [No Abstract]   [Full Text] [Related]  

  • 24. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.
    Bowden CL; Grunze H; Mullen J; Brecher M; Paulsson B; Jones M; Vågerö M; Svensson K
    J Clin Psychiatry; 2005 Jan; 66(1):111-21. PubMed ID: 15669897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
    Hirschfeld RM; Weisler RH; Raines SR; Macfadden W;
    J Clin Psychiatry; 2006 Mar; 67(3):355-62. PubMed ID: 16649820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quetiapine discontinuation syndrome.
    Kim DR; Staab JP
    Am J Psychiatry; 2005 May; 162(5):1020. PubMed ID: 15863814
    [No Abstract]   [Full Text] [Related]  

  • 27. [Sustained leukopenia probably related to quetiapine].
    Lobato MI; Crestana T; Onsten TG
    Braz J Psychiatry; 2005 Dec; 27(4):346. PubMed ID: 16358125
    [No Abstract]   [Full Text] [Related]  

  • 28. First controlled treatment trial of bipolar II hypomania with mixed symptoms: quetiapine versus placebo.
    Suppes T; Ketter TA; Gwizdowski IS; Dennehy EB; Hill SJ; Fischer EG; Snow DE; Gonzalez R; Sureddi S; Shivakumar G; Cosgrove VE
    J Affect Disord; 2013 Aug; 150(1):37-43. PubMed ID: 23521871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety, tolerability, and efficacy of quetiapine in youth with schizophrenia or bipolar I disorder: a 26-week, open-label, continuation study.
    Findling RL; Pathak S; Earley WR; Liu S; DelBello M
    J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):490-501. PubMed ID: 24024534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quetiapine for treatment-resistant mania.
    Dunayevich E; Strakowski SM
    Am J Psychiatry; 2000 Aug; 157(8):1341. PubMed ID: 10910805
    [No Abstract]   [Full Text] [Related]  

  • 31. 3 case reports of edema associated with quetiapine.
    Koleva HK; Erickson MA; Vanderlip ER; Tansey J; Mac J; Fiedorowicz JG
    Ann Clin Psychiatry; 2009; 21(2):77-80. PubMed ID: 19439156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substantial weight gain associated with severe carbohydrate craving in a patient receiving quetiapine.
    Kluge M; Dietzel J
    Psychiatry Clin Neurosci; 2013 Apr; 67(3):189-90. PubMed ID: 23581871
    [No Abstract]   [Full Text] [Related]  

  • 33. Combination treatment with quetiapine in bipolar disorder patients.
    Basu D; Chakraborty K
    Am J Psychiatry; 2009 Oct; 166(10):1185; author reply 1186-7. PubMed ID: 19797447
    [No Abstract]   [Full Text] [Related]  

  • 34. Severe hyperlipidemia associated with olanzapine and quetiapine use.
    Carnahan RM; Reantaso AA; Teegarden BA; Pogue T
    Am J Psychiatry; 2007 Oct; 164(10):1614-5. PubMed ID: 17898359
    [No Abstract]   [Full Text] [Related]  

  • 35. The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s).
    Barzman DH; DelBello MP; Adler CM; Stanford KE; Strakowski SM
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):665-70. PubMed ID: 17201610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early onset of action and sleep-improving effect are crucial in decreasing suicide risk: the role of quetiapine XR in the treatment of unipolar and bipolar depression.
    Pompili M; Rihmer Z; Gonda X; Serafini G; Sher L; Girardi P
    Riv Psichiatr; 2012; 47(6):489-97. PubMed ID: 23160109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tardive dyskinesia with quetiapine.
    Ghelber D; Belmaker RH
    Am J Psychiatry; 1999 May; 156(5):796-7. PubMed ID: 10327920
    [No Abstract]   [Full Text] [Related]  

  • 38. Symptom reduction and suicide risk among patients treated with placebo in antipsychotic clinical trials: an analysis of the food and drug administration database.
    Khan A; Khan SR; Leventhal RM; Brown WA
    Am J Psychiatry; 2001 Sep; 158(9):1449-54. PubMed ID: 11532730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA; Brecher M; Paulsson B
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quetiapine-induced weight gain and escitalopram.
    Holzer L; Paiva G; Halfon O
    Am J Psychiatry; 2005 Jan; 162(1):192-3. PubMed ID: 15625223
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.